Sharetry is a wholly-owned subsidiary of Sharay, a high-tech enterprise that integrates the research and development, registration, production, sales, and market resources of medical device products.

Based on the medical device registrant system, the company has established a professional CXO service platform for in vitro diagnostic products, providing full life cycle services for contract development manufacturing organization (CDMO), contract regulatory associations organization (CRAO), contract manufacturing organization (CMO) , and Clinical Research Organization(CRO) of in vitro diagnostic reagents and instruments, The company is committed to becoming the world's leading third-party in vitro diagnostic product CXO service platform.

The company's 3C service platform product menu includes luminescence, coagulation, biochemistry, and specific proteins, covering the entire industry chain of in vitro diagnosis. Currently, it has served nearly a hundred industrial customers at home and abroad and has become a top supplier of one-stop solutions for in vitro diagnosis products. At the same time, the company has developed over a hundred core raw materials for diagnostic reagents (mainly antibodies, autoimmune antigens, and component allergens), which have been widely used in downstream kit development.

Sharay takes technological innovation as its responsibility and adheres to the company's development policy of "high starting point, strict standards". It always upholds innovation, adheres to research and development from the source of technology, and harbors the ideal of "becoming a leading in vitro diagnostic enterprise in the world". It exports high-quality Chinese services and diagnostic products to the world, providing guarantees for the vast number of patients.